CITIUS ONCOLOGY, INC. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q3 2023 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Citius Oncology, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q3 2023 to Q3 2024.
- Citius Oncology, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending September 30, 2024 was $7.53M, a 62.1% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)